Cherry Creek Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History
Cherry Creek Investment Advisors, Inc.
- $178 Million
- Q1 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 6,704 shares of GILD stock, worth $430,866. This represents 0.28% of its overall portfolio holdings.
Number of Shares
6,704
Previous 6,783
1.16%
Holding current value
$430,866
Previous $549,000
10.56%
% of portfolio
0.28%
Previous 0.35%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,884Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$7.88 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.37 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.43 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$3.94 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.71 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $80.6B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...